We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current DEST market cap is 16.67M. The company's latest EPS is GBP -0.0683 and P/E is -2.56.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.21M | -5.54M | -6.54M | -6.3M | -7.78M |
| Net Income | -5.17M | -4.71M | -5.41M | -5.34M | -6.5M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 13.06M | 8.56M | 13.7M | 8.28M | 8.8M |
| Total Liabilities | 801k | 798k | 1.27M | 774k | 1.17M |
| Total Equity | 12.26M | 7.76M | 12.44M | 7.51M | 7.63M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -4.72M | -4.63M | -5.49M | -5.09M | 4.9M |
| Investing | 58k | 5.04M | -2.19M | -15k | N/A |
| Financing | N/A | 7k | 9.95M | 7k | N/A |
| Market Cap | 16.67M |
| Price to Earnings Ratio | -2.56 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.9 |
| Price to Book Ratio | 2.19 |
| Dividend Yield | - |
| Shares Outstanding | 95.27M |
| Average Volume (1 week) | 2.17M |
| Average Volume (1 Month) | 926.05k |
| 52 Week Change | -49.28% |
| 52 Week High | 83.00 |
| 52 Week Low | 13.50 |
| Spread (Intraday) | 1 (5.56%) |
| Company Name | Destiny Pharma Plc |
| Address |
sussex innovation centre brighton & hove BN1 9SB |
| Website | https://www.destinypharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
